Psilocybin therapy for anxiety in cancer patients
Part of Cancer, Digestive system, Hormones & metabolism, Kidney & urinary, Mental health, Skin, Women’s health & pregnancy clinical trials.
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A diagnosis of adjustment disorder related to cancer with significant anxiety symptoms
- Adults aged 18 to 80 with any type of cancer (excluding certain brain or advanced tumors) and a life expectancy of at least 6 months
- Agree to avoid starting new psychiatric medications or therapies during the first 10 weeks of the study
- Be in generally good health aside from cancer, with no major heart, liver, kidney, or seizure problems
- Agree to stop certain medications (like sedatives) and recreational drugs before the psilocybin session
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a single dose of psilocybin, given with therapy, can help cancer survivors who struggle with anxiety or depression. You would travel to MD Anderson for treatment and follow-up, and must stop certain medications beforehand.
This Phase 2 study tests whether MDMA-assisted therapy can reduce adjustment-related distress in cancer patients who are paired with a loved one who is also concerned. It may help the patient and their significant other cope better through structured therapy sessions, with safety checks before and after each session.
This trial tests whether a drug called psilocybin, given with therapy, can help people with advanced cancer who are feeling anxious or depressed. You must have a stable cancer and be willing to travel to Houston for treatment.
This trial studies whether psilocybin (with support and therapy) can reduce anxiety in people with advanced cancer. It may help with distress and quality of life, while the study team monitors safety closely.
This trial tests if a medicine called psilocybin, given with talk therapy, can safely help people with advanced cancer who feel very demoralized. Demoralization is a deep sense of hopelessness or loss of meaning. The goal is to see if this treatment can improve your emotional well-being.
This trial tests if psilocybin-assisted therapy can help reduce the intense worry that cancer might come back. It is for people who have finished their main treatments for early-stage breast cancer or advanced ovarian cancer.
Hear when a new Adjustment Disorder With Anxious Mood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.